Enhanced Prothrombin and lntrinsic Factor X Activation on Blood Platelets from Diabetic Patients

Summary

The present work was conducted to bring information about the enhanced procoagulant activity of blood platelets in diabetes mellitus, as compared to normal control platelets. The inquiry was performed on platelets from either human patients or hamsters with streptozotocin-induced diabetes. The experiments comprised functional assays of factor Xa and thrombin generation in the presence of normal or diabetic platelets, using saturating amounts of coagulation factors. The prothrombinasic and tenasic complexes activation was measured by using discontinuous amidolytic tests with chromogenic substrates (S-2238 for FXa and S-2222 for thrombin). The results showed that, in contrast to the low prothrombin and factor X converting activity of normal platelets, the thrombin and FXa generation on diabetic platelets was increased by 3-7 times for either humans or hamsters. These findings may be relevant for the pathogenesis of thrombotic complications known to occur in diabetes mellitus.

• References

• 1 Bevers EM, Comfurius P, Zwaal RFA. Platelet procoagulant activity. Physiological significance and mechanism of exposure. Blood Rev 1991; 5: 146-154
• 2 Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990; 76: 1-16
• 3 Zwaal RFA. Membrane and lipid involvement in blood coagulation. Biochim Biophys Acta 1978; 515: 163-205
• 4 Bevers EM, Comfurius P, Zwaal RFA. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736: 57-66
• 5 Rosing J, van Rijn JLML, Bevers EM, van Dieijen G, Comfurius P, Zwaal RFA. The role of activated human platelets in prothrombin and factor X activation. Blood 1985; 65: 319-332
• 6 Rao AK, Goldberg RE, Walsh PN. Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume. J Lab Clin Med 1984; 103: 82-92
• 7 Garcia-Frade LJ, de la Calle H, Alava I, Navarro JL, Creighton LJ, Gaffney PJ. Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage. Thromb Res 1987; 47: 533-540
• 8 Ostermann H, van de Loo J. Factors of the hemostatic system in diabetic patients: a survey of controlled studies. Haemostasis 1986; 16: 386-416
• 9 Lupu F, Calb M, Fixman A. Alterations of phospholipid asymmetry in the membrane of spontaneously aggregated platelets in diabetes. Thromb Res 1988; 50: 605-612
• 10 Van Rijn J, Rosing J, Van Diejien G. Activity of human blood platelets in prothrombin and Factor X activation induced by ionophore A 23187. Eur J Biochem 1983; 133: 1-10
• 11 Kane WN, Majerus PW. The interaction of human coagulation factor Va with platelets. J Biol Chem 1982; 257: 3963-3970
• 12 Bevers EM, Comfurius P, Nieuwenhuis HK. Platelet prothrombin converting activity in hereditary disorders of platelet function. Br J Haematol 1986; 63: 335-345
• 13 Strano A, Davi G, Patrono C. In vivo platelet activation in diabetes mellitus. Semin Thromb Haemostas 1991; 17: 422-425
• 14 Jude B, Fontaine P. Modifications of the monocyte procoagulant activity in diabetes mellitus. Semin Thromb Haemostas 1991; 17: 445-447
• 15 van Wersch JWJ, Westerhuis LWJJM, Venekamp WJRR. Coagula-tion activation in diabetes mellitus. Haemostasis 1990; 20: 263-269
• 16 Ceriello A, Dello RussoP, Zuccotti C, Florio A, Nazarro S, Pietrantuono C, Rosato GB. Decreased antithrombin III activity in diabetes may be due to nonenzymatic glycosylation: a preliminary report. Thromb Haemostas 1983; 50: 633-634